• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

视力损害、年龄相关性黄斑变性、白内障与长期死亡率:蓝山眼研究

Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study.

作者信息

Cugati Sudha, Cumming Robert G, Smith Wayne, Burlutsky George, Mitchell Paul, Wang Jie Jin

机构信息

Centre for Vision Research, Department of Ophthalmology, Westmead Millennium Institute, University of Sydney, Westmead Hospital, Westmead, New South Wales, Australia.

出版信息

Arch Ophthalmol. 2007 Jul;125(7):917-24. doi: 10.1001/archopht.125.7.917.

DOI:10.1001/archopht.125.7.917
PMID:17620571
Abstract

OBJECTIVE

To assess the association of visual impairment, age-related macular degeneration (ARMD), and cataract with long-term mortality.

METHODS

At baseline, 3654 persons 49 years and older were examined in the Blue Mountains Eye Study (1992-1994). Standardized photographic grading was used to assess ARMD and cataract. Mortality and causes of death occurring between baseline and December 31, 2003, were obtained via data linkage with the Australian National Death Index. Age-standardized mortality rates were calculated. Hazard ratios (HRs) and 95% confidence intervals (CIs) were assessed using Cox models. Result Age-standardized mortality was higher in persons with vs without visual impairment (54.0% vs 34.0%), ARMD (45.8% vs 33.7%), and cataract (39.2% vs 29.5%). After adjusting for factors that predict mortality, neither visual impairment (HR, 1.3; 95% CI, 0.98-1.7) nor ARMD (HR, 1.0; 95% CI, 0.8-1.3) was significantly associated with all-cause mortality in all ages. Among persons younger than 75 years, however, ARMD predicted higher all-cause mortality (HR, 1.6; 95% CI, 1.0-2.4). Any cataract (HR, 1.3; 95% CI, 1.0-1.5) and cortical (HR, 1.2; 95% CI, 0.97-1.4), nuclear (HR, 1.2; 95% CI, 0.98-1.5), and posterior subcapsular (HR, 1.3; 95% CI, 1.0-1.7) cataract were also associated with higher all-cause mortality.

CONCLUSION

Cataract predicted increased mortality in persons 49 years and older, and ARMD predicted mortality in persons aged 49 to 74 years.

摘要

目的

评估视力损害、年龄相关性黄斑变性(ARMD)和白内障与长期死亡率之间的关联。

方法

在基线期,对蓝山眼研究(1992 - 1994年)中3654名49岁及以上的人进行了检查。采用标准化摄影分级来评估ARMD和白内障。通过与澳大利亚国家死亡指数的数据链接,获取基线期至2003年12月31日期间的死亡率和死亡原因。计算年龄标准化死亡率。使用Cox模型评估风险比(HRs)和95%置信区间(CIs)。结果有视力损害者与无视力损害者相比,年龄标准化死亡率更高(54.0%对34.0%),ARMD患者(45.8%对33.7%)以及白内障患者(39.2%对29.5%)。在对预测死亡率的因素进行调整后,视力损害(HR,1.3;95% CI,0.98 - 1.7)和ARMD(HR,1.0;95% CI,0.8 - 1.3)在所有年龄段与全因死亡率均无显著关联。然而,在75岁以下人群中,ARMD预示着更高的全因死亡率(HR,1.6;95% CI,1.0 - 2.4)。任何类型的白内障(HR,1.3;95% CI,1.0 - 1.5)以及皮质性(HR,1.2;95% CI,0.97 - 1.4)、核性(HR,1.2;95% CI,0.98 - 1.5)和后囊下(HR,1.3;95% CI,1.0 - 1.7)白内障也与更高的全因死亡率相关。

结论

白内障预示着49岁及以上人群死亡率增加,ARMD预示着49至74岁人群死亡率增加。

相似文献

1
Visual impairment, age-related macular degeneration, cataract, and long-term mortality: the Blue Mountains Eye Study.视力损害、年龄相关性黄斑变性、白内障与长期死亡率:蓝山眼研究
Arch Ophthalmol. 2007 Jul;125(7):917-24. doi: 10.1001/archopht.125.7.917.
2
Correction of visual impairment by cataract surgery and improved survival in older persons: the Blue Mountains Eye Study cohort.白内障手术矫正视力损害和提高老年人生存率:蓝山眼研究队列。
Ophthalmology. 2013 Sep;120(9):1720-7. doi: 10.1016/j.ophtha.2013.02.009. Epub 2013 May 9.
3
Age-related eye disease, visual impairment, and survival: the Beaver Dam Eye Study.年龄相关性眼病、视力损害与生存:比弗迪尔姆眼科研究
Arch Ophthalmol. 2006 Feb;124(2):243-9. doi: 10.1001/archopht.124.2.243.
4
Direct and indirect effects of visual impairment on mortality risk in older persons.视力障碍对老年人死亡风险的直接和间接影响。
Arch Ophthalmol. 2009 Oct;127(10):1347-53. doi: 10.1001/archophthalmol.2009.240.
5
Visual impairment corrected via cataract surgery and 5-year survival in a prospective cohort.白内障手术后视力矫正和前瞻性队列研究 5 年生存率。
Am J Ophthalmol. 2014 Jan;157(1):163-170.e1. doi: 10.1016/j.ajo.2013.08.018. Epub 2013 Oct 22.
6
Visual impairment, age-related cataract, and mortality.视力损害、年龄相关性白内障与死亡率。
Arch Ophthalmol. 2001 Aug;119(8):1186-90. doi: 10.1001/archopht.119.8.1186.
7
Open-angle glaucoma and cardiovascular mortality: the Blue Mountains Eye Study.开角型青光眼与心血管疾病死亡率:蓝山眼研究
Ophthalmology. 2006 Jul;113(7):1069-76. doi: 10.1016/j.ophtha.2006.02.062.
8
Association of Mortality with Ocular Diseases and Visual Impairment in the Age-Related Eye Disease Study 2: Age-Related Eye Disease Study 2 Report Number 13.与年龄相关性眼病研究 2 中的死亡率与眼部疾病和视力障碍的关系:年龄相关性眼病研究 2 报告第 13 号。
Ophthalmology. 2018 Apr;125(4):512-521. doi: 10.1016/j.ophtha.2017.10.028. Epub 2017 Nov 16.
9
Adherence to dietary guidelines and the 10-year cumulative incidence of visual impairment: the Blue Mountains Eye Study.遵循饮食指南与视力损害的10年累积发病率:蓝山眼研究
Am J Ophthalmol. 2014 Aug;158(2):302-8. doi: 10.1016/j.ajo.2014.05.011. Epub 2014 May 17.
10
Discriminative power of reading tests to differentiate visual impairment caused by cataract and age-related macular degeneration.阅读测试在鉴别白内障和年龄相关性黄斑变性所致视力损害方面的辨别能力。
J Cataract Refract Surg. 2005 Nov;31(11):2111-9. doi: 10.1016/j.jcrs.2005.03.080.

引用本文的文献

1
The average life expectancy of persons with disabilities in China.中国残疾人的平均预期寿命。
SSM Popul Health. 2023 Oct 3;24:101526. doi: 10.1016/j.ssmph.2023.101526. eCollection 2023 Dec.
2
Mechanistic Insight into Age-Related Macular Degeneration (AMD): Anatomy, Epidemiology, Genetics, Pathogenesis, Prevention, Implications, and Treatment Strategies to Pace AMD Management.年龄相关性黄斑变性(AMD)的机制性见解:解剖学、流行病学、遗传学、发病机制、预防、意义及加速AMD管理的治疗策略
Chonnam Med J. 2023 Sep;59(3):143-159. doi: 10.4068/cmj.2023.59.3.143. Epub 2023 Sep 25.
3
Association of glaucoma with 10-year mortality in a population-based longitudinal study in urban Southern China: the Liwan Eye Study.
基于人群的中国南方城市纵向研究中青光眼与 10 年死亡率的关系:荔湾眼病研究。
BMJ Open. 2021 Oct 7;11(10):e040795. doi: 10.1136/bmjopen-2020-040795.
4
Cost-effectiveness analysis of ranibizumab for retinal vein occlusion patients in China from the societal perspective.从社会角度评估雷珠单抗治疗视网膜静脉阻塞患者的成本效果分析。
BMC Ophthalmol. 2021 May 24;21(1):229. doi: 10.1186/s12886-021-01997-1.
5
Objectively measured far vision impairment and sarcopenia among adults aged ≥ 65 years from six low- and middle-income countries.来自六个中低收入国家的年龄≥65 岁成年人的客观远视力损害和肌肉减少症。
Aging Clin Exp Res. 2021 Nov;33(11):2995-3003. doi: 10.1007/s40520-021-01841-y. Epub 2021 Mar 28.
6
Geographic atrophy severity and mortality in age-related macular degeneration.年龄相关性黄斑变性的地理萎缩严重程度和死亡率。
Graefes Arch Clin Exp Ophthalmol. 2021 Sep;259(9):2643-2651. doi: 10.1007/s00417-021-05145-9. Epub 2021 Mar 19.
7
Association between vision impairment and mortality: a systematic review and meta-analysis.视力障碍与死亡率的关联:系统评价和荟萃分析。
Lancet Glob Health. 2021 Apr;9(4):e418-e430. doi: 10.1016/S2214-109X(20)30549-0. Epub 2021 Feb 16.
8
Cataract risk stratification and prioritisation protocol in the COVID-19 era.COVID-19 时代的白内障风险分层和优先级排序协议。
BMC Health Serv Res. 2021 Feb 17;21(1):153. doi: 10.1186/s12913-021-06165-1.
9
Self-reported visual difficulties in Europe and related factors: a European population-based cross-sectional survey.欧洲人群中自我报告的视觉困难及相关因素:一项基于人群的欧洲横断面调查。
Acta Ophthalmol. 2021 Aug;99(5):559-568. doi: 10.1111/aos.14643. Epub 2020 Oct 7.
10
Mortality and causes of death in a population with blindness in Korea: A longitudinal follow-up study using a national sample cohort.韩国盲人群体的死亡率和死因:一项使用全国样本队列的纵向随访研究。
Sci Rep. 2020 Mar 17;10(1):4891. doi: 10.1038/s41598-020-61805-6.